Employers understand what accountable care organizations are, but they need a better understanding of how they deliver value better than the market, explained Brian Marcotte, president and CEO of the National Business Group on Health
Employers understand what accountable care organizations are, but they need a better understanding of how they deliver value better than the market, explained Brian Marcotte, president and CEO of the National Business Group on Health
Transcript (slightly modified)
How well do employers currently understand what accountable care organizations are and what they offer?
I think that employers understand the concept of ACOs. ACOs are providers coming together in a delivery system to take on responsibility for the care and the cost of a defined population. So, they get that. I think where employers struggle is understanding how they deliver value better than the market. If I have a health plan coming into me and I have a relationship with a national health plan, and they have 150 ACOs that they can deploy across my population because I’m in every state. I don’t know how to react to that as an employer. How do I differentiate the value that those ACOs are providing, from what I have in place today from a cost, a quality, and a consumer experience perspective?
Is there an education process the National Business Group on Health provides to help employers better understand what ACOs offer?
What we’ve done is we’ve put health plans, healthcare providers, even ACO providers, and employers together to see if we can all agree on what the market expectations of ACOs are. What are the key domains? What are the core competencies that an ACO must have? How do those competencies evolve over time, from an early stage to a much more mature stage? The goal here is to give employers the confidence to recognize: What’s the ask? What am I looking for from an ACO? But also, for a health plan to be able to bring in to an employer, with confidence themselves, as to how ACOs differentiate in the market from what they offer today. It also provides a road map for ACOs of: Where do I need to be from an employer perspective if I want an employer to engage with me? So, it’s trying to get everyone to speak the same language, and to talk about things in the same way, and to recognize what the tipping point from a value perspective is to move forward.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More